Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice.

Khalil MH, Marcelletti JF, Katz LR, Katz DH, Pope LE.

Contact Dermatitis. 2000 Aug;43(2):79-81.

PMID:
10945745
2.

Docosanol: new drug. Herpes labialis: barely more effective than an excipient.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):106-7.

PMID:
19637417
4.

Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.

Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, Jorizzo JL, Gunnill LB, Katz DH, Khalil MH, Morrow PR, Yakatan GJ, Pope LE, Berg JE; Docosanol 10% Cream Study Group..

J Am Acad Dermatol. 2001 Aug;45(2):222-30.

PMID:
11464183
5.

Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice.

Mikus D, Sikiric P, Seiwerth S, Petricevic A, Aralica G, Druzijancic N, Rucman R, Petek M, Pigac B, Perovic D, Kolombo M, Kokic N, Mikus S, Duplancic B, Fattorini I, Turkovic B, Rotkvic I, Mise S, Prkacin I, Konjevoda P, Stambuk N, Anic T.

Burns. 2001 Dec;27(8):817-27.

PMID:
11718984
6.

Topical n-docosanol for management of recurrent herpes labialis.

Treister NS, Woo SB.

Expert Opin Pharmacother. 2010 Apr;11(5):853-60. doi: 10.1517/14656561003691847. Review.

PMID:
20210688
7.

Dietary, but not topical, alpha-linolenic acid suppresses UVB-induced skin injury in hairless mice when compared with linoleic acids.

Takemura N, Takahashi K, Tanaka H, Ihara Y, Ikemoto A, Fujii Y, Okuyama H.

Photochem Photobiol. 2002 Dec;76(6):657-63.

PMID:
12511046
8.

Docosanol: a topical antiviral for herpes labialis.

Leung DT, Sacks SL.

Expert Opin Pharmacother. 2004 Dec;5(12):2567-71. Review.

PMID:
15571473
9.
12.

Evaluation of lotion formulations on irritation using the modified forearm-controlled application test method.

Farage MA, Ebrahimpour A, Steimle B, Englehart J, Smith D.

Skin Res Technol. 2007 Aug;13(3):268-79.

PMID:
17610648
13.

Efficacy of docosanol.

Sacks SL.

J Am Acad Dermatol. 2003 Sep;49(3):558-9. No abstract available.

PMID:
12963936
14.

[Docosanol (Erazaban), dermal use].

[No authors listed]

J Pharm Belg. 2011 Jun;(2):53-4. French. No abstract available.

PMID:
21823443
15.

Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice.

Sikiric P, Seiwerth S, Mise S, Staresinic M, Bedekovic V, Zarkovic N, Borovic S, Gjurasin M, Boban-Blagaic A, Batelja L, Rucman R, Anic T.

Burns. 2003 Jun;29(4):323-34.

PMID:
12781609
16.

Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.

Matsumoto K, Mizukoshi K, Oyobikawa M, Ohshima H, Sakai Y, Tagami H.

Skin Res Technol. 2005 Aug;11(3):209-17.

PMID:
15998334
17.
18.

Topical treatments for hydrofluoric acid burns: a blind controlled experimental study.

Höjer J, Personne M, Hultén P, Ludwigs U.

J Toxicol Clin Toxicol. 2002;40(7):861-6.

PMID:
12507055
19.

Nonspecific hypersensitivity of the skin.

van der Lugt L, Veninga TS.

Dermatologica. 1981;162(6):438-43.

PMID:
7274505
20.

Efficacy of a skin-protective foam in the treatment of chronic hand dermatitis.

Fowler JF Jr.

Am J Contact Dermat. 2000 Sep;11(3):165-9.

PMID:
11012005

Supplemental Content

Support Center